ABT.SW Abbott Laboratories is showing an extreme oversold reading (RSI 4.70) pre-market on February 19, 2026, trading at CHF100.00, which often precedes a short-term bounce. Despite a premium valuation (PE 34.84), the company has strong cash metrics and solid liquidity. Traders are advised to wait for confirmation of a bounce, such as a volume-backed green candle or RSI recovery above 30.00, before targeting CHF106.00 and CHF109.55.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ABT.SW Abbott Laboratories CHF100.00 pre-market 19 Feb 2026: Oversold bounce
ABT.SW Abbott Laboratories is showing an extreme oversold reading (RSI 4.70) pre-market on February 19, 2026, trading at CHF100.00, which often precedes a short-term bounce. Despite a premium valuation (PE 34.84), the company has strong cash metrics and solid liquidity. Traders are advised to wait for confirmation of a bounce, such as a volume-backed green candle or RSI recovery above 30.00, before targeting CHF106.00 and CHF109.55.